BALAXI - Balaxi Pharmaceuticals

Balaxi Pharmaceuticals

BALAXI · Retail > Trading · MD: Ashish Maheshwari · Listing date: Nov. 30, 2015 · Hyderabad · http://www.balaxiventures.in/

Stock Price vs Company Growth

4.3%

4.7%

21.2%

39.7%

45.2%

63.3%

26.7%

10y

17.5%

all

25.5%

🤔 How to analyze this graph?

Last Traded Price

₹ 27.1 4.3%

25.9

45.3

Company Overview

Sales

276 Cr

Growth: 8.8%

Profit after Tax

14.5 Cr

Growth: -23.2%

Micro Cap

149 Cr

P/E: 10.3x

Industry P/E: 28.9x

Fundamentals

Sales (Cr)	₹ 276
Growth	8.8%
EBITDA	7.9%
P/S	0.5x
Dividend	0.0%
P/E	10.3x
Book Value	₹ 31.7
PEG Ratio	1.2x
ROE	8.4%
P/B	0.9x

Shareholding Pattern

Institutions

Elara India Opportunities Fund Limited

9.5 %

Marshal Global Capital Fund Ltd

9.5 %

Amol Anand Mantri

1.73 %

Iepf

0.75 %

Promoters

Balaxi Overseas Private Limited

70.0 %

Ashish Maheshwari

1.81 %

Minoshi Maheshwari

1.06 %

Others

Increase Decrease No change

Company Profile Detailed

The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG productsHistory and Milestones2003-07Commenced Pharmaceutcal business by supplying white labeled products to customers in Africa.Sourcing was from WHO GMP certified plants based in India.2008-10Created frontend presence for its Pharmaceutical Business by setting up 1st wholesale depot in Angola in 2008.

Investors (19)

nexpact

balaxi.o...

iepf

Followers (1)

gmuralik